Accuray Incorporated - Common Stock (ARAY)

3.1900
-0.6300 (-16.49%)
NASDAQ · Last Trade: Nov 10th, 5:02 PM EST
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close3.820
Open3.790
Bid3.050
Ask3.220
Day's Range2.880 - 3.970
52 Week Range3.550 - 48.40
Volume262,379
Market Cap305.45M
PE Ratio (TTM)-79.75
EPS (TTM)-0.0
Dividend & YieldN/A (N/A)
1 Month Average Volume58,878

Chart

About Accuray Incorporated - Common Stock (ARAY)

Accuray Inc is a leading innovator in cancer treatment technologies, primarily focusing on advanced radiation therapy solutions. The company specializes in the development of systems that deliver precise and targeted radiation to tumors, aiming to maximize therapeutic efficacy while minimizing damage to surrounding healthy tissue. Accuray's flagship products, including the CyberKnife and TomoTherapy systems, are designed to improve patient outcomes through increased accuracy and flexibility in treatment planning. Through its commitment to innovative engineering and clinical excellence, Accuray plays a significant role in enhancing the landscape of cancer care. Read More

News & Press Releases

Accuray (ARAY) Q1 2027 Earnings Call Transcriptfool.com
Service margins and cost cuts offset a product revenue slide.
Via The Motley Fool · November 5, 2026
Accuray (NASDAQ:ARAY) Slides as Revenue Miss Outweighs EPS Beatchartmill.com
Via Chartmill · November 4, 2026
After-Hours Market Movers: Nov. 4, 2026 Gainers and Loserschartmill.com
Via Chartmill · November 4, 2026
After-Hours US Movers: STAK, NCPL, CRMT Gain; NVEC, HKPD, LHSW Fallchartmill.com
Via Chartmill · October 21, 2026
Accuray Inc (NASDAQ:ARAY) Plunges 12.5% After Fiscal Q3 Earnings Misschartmill.com
Via Chartmill · May 6, 2026
Accuray Incorporated (NASDAQ:ARAY) Plunges Over 13% on Weak Guidance Despite Narrow Earnings Beatchartmill.com
Via Chartmill · February 4, 2026
VivoSim Labs Inc. (NASDAQ: VIVS) Targets the Multibillion-Dollar Cost of Failed Drugs
Dallas TX - Sept. 28, 2026 - VivoSim Labs Inc. (NASDAQ: VIVS) is developing human-relevant testing technologies designed to identify unsuccessful drug candidates earlier, potentially improving the economics of pharmaceutical development.
Via AB Newswire · September 28, 2026
American Fusion (OTCQB: AMFN) Expands Texatron™ Patent Portfolio as Uplisting Plans Advance
Dallas TX - Sept. 28, 2026 - American Fusion Inc. (OTCQB: AMFN) has filed 21 additional U.S. patent applications, bringing its Texatron™ intellectual-property portfolio to 151 pending U.S. applications, as the company continues testing its fusion-energy platform and prepares for a potential national-exchange listing.
Via AB Newswire · September 28, 2026
Top stock movements in today's session.chartmill.com
Via Chartmill · September 28, 2026
Check out the stocks that are attracting the most attention and driving market activity.chartmill.com
Via Chartmill · September 28, 2026
Let's take a look at the stocks that are in motion in today's session.chartmill.com
Via Chartmill · September 28, 2026
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Via Chartmill · September 28, 2026
These stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · September 28, 2026
Accuray (ARAY) Q4 2026 Earnings Call Transcriptfool.com
Transformation plan delivered $20M in cost savings as China headwinds pressured product revenue 42%.
Via The Motley Fool · August 26, 2026
Accuray Q4 2026 Earnings Call: Complete Transcriptbenzinga.com
Accuray (NASDAQ:ARAY) released fourth-quarter financial results and hosted an earnings call on Wednesday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts and
Via Benzinga · August 19, 2026
Thursday's after hours session: top gainers and loserschartmill.com
Via Chartmill · July 16, 2026
These stocks are moving in today's after hours sessionchartmill.com
Via Chartmill · May 15, 2026
Which stocks are experiencing notable movement on Thursday?chartmill.com
Via Chartmill · May 7, 2026
Accuray (ARAY) Q3 2026 Earnings Transcriptfool.com
Accuray (ARAY) Q3 2026 Earnings Transcript
Via The Motley Fool · May 6, 2026
Medical Technology Alert: BSX, TFX, ARAY, CSDX, NDRA Emerging Across Cancer Treatment and GLP-1 Healthcare Ecosystems
The global absorbable hydrogel tissue spacer market, used primarily in prostate cancer radiation therapy , is gaining momentum as healthcare providers increasingly adopt technologies designed to reduce treatment side effects while improving patient outcomes.
Via AB Newswire · March 11, 2026
Get insights into the top gainers and losers of Friday's after-hours session.chartmill.com
Via Chartmill · February 20, 2026
Accuray (ARAY) Q2 2026 Earnings Call Transcriptfool.com
Accuray (ARAY) Q2 2026 Earnings Call Transcript
Via The Motley Fool · February 4, 2026
Curious about the stocks that are showing activity after the closing bell on Wednesday?chartmill.com
Via Chartmill · February 4, 2026
CS Diagnostics (OTCQB: CSDX) Advances Infection Control and Oncology Innovation Plus – IVP, SAFX, JTAI, OCG, BMXI Inside
Medical technology, infection control systems, oncology radiotherapy solutions, and diagnostics innovation remain key healthcare growth themes heading into 2026—and CS Diagnostics Corp. (OTCQB: CSDX) is positioning itself at the intersection of both.
Via AB Newswire · January 14, 2026
12 Health Care Stocks Moving In Thursday's Pre-Market Sessionbenzinga.com
Via Benzinga · November 6, 2025